COc1ccc(N2CCN(c3cc(C(=O)Nc4cc(OC)c(OC)c(OC)c4)ncn3)CC2)cc1OC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?